Cell therapies are revolutionizing the treatment of disease and are poised to transform health outcomes.
Advances in biology and technology have enabled the development of innovation in a more distributed way than ever before: there is a wave of novel therapeutics in academic centers and biotechs around the world looking for partners to advance their inventions.
That’s where we come in.
Our approach is to bring clinical stage therapies through late stage development and commercialization by partnering with innovators at academic medical centers and small biotechs around the world.
Headquartered in San Francisco, CA, the company is backed by seed investment from National Resilience, Inc., Hibiscus BioVentures, and Jumpstart Nova, as well as several high-net-worth individuals.
Advances in biology and technology have enabled the development of innovation in a more distributed way than ever before: there is a wave of novel therapeutics in academic centers and biotechs around the world looking for partners to advance their inventions.
That’s where we come in.
Our approach is to bring clinical stage therapies through late stage development and commercialization by partnering with innovators at academic medical centers and small biotechs around the world.
Headquartered in San Francisco, CA, the company is backed by seed investment from National Resilience, Inc., Hibiscus BioVentures, and Jumpstart Nova, as well as several high-net-worth individuals.
Location: United States, California, San Francisco
Employees: 1-10
Founded date: 2020
Investors 1
| Date | Name | Website |
| 04.10.2021 | Cavendish ... | cavendishf... |
Mentions in press and media 5
| Date | Title | Description |
| 24.02.2022 | This Nashville-based VC is addressing racial inequalities in health care with a fund backed by Eli Lilly, Cardinal Health, and others | Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you. Marcus Whitney stands out in Nashville’s $95 billion health care sector as an investor in startups. In add... |
| 14.01.2022 | Jumpstart Health Launches $55M Venture Fund for Black Founded Health Startups | Marcus Whitney, Jumpstart Health Investors Co-Founder & Partner What You Should Know: – Jumpstart Health Investors, announced this week the launch of Jumpstart Nova, the first venture fund to invest in Black founded and led healthcare i... |
| 12.01.2022 | Pinnacle Financial Partners : Partners with Jumpstart Nova, the First Venture Fund to Invest Exclusively in Black Founded and Led Healthcare Companies in the U.S. | January 12, 2022 In partnership with global financial institutions and leading national healthcare organizations, Jumpstart Nova announces the close of its $55M oversubscribed fund to invest exclusively in Black-founded and led companies at... |
| - | Black-led VC fund aims to even the playing field for minority health-tech startups | For Black-led startups, the lack of diversity in venture capital can pose a hurdle to access funding The number of women and minority-owned venture and private equity funds rose 25% the year after the George Floyd protests, according to Fai... |
| - | Healthcare firms were pushed to confront racism. Now some are investing in Black startups. | Marcus Whitney stands out in Nashville’s $95 billion healthcare sector as an investor in startups. In addition to co-founding a venture capital firm, he’s organized an annual health tech conference and co-founded the city’s professional soc... |